STSS
Sharps Technology, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.27
−2.31%Year over year
Reported trailing growth
- Revenue
- +1021.5%
- EBITDA
- —
- EBIT
- —
- EPS
- +98.8%
- Free cash flow
- -70.0%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- -69.2%
- Net income
- —
- EPS
- +99.5%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026